Cubist Systematic Strategies’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Buy |
+218,837
| New | +$3M | 0.01% | 623 |
|
|
2024
Q4 | – | Sell |
-13,361
| Closed | -$170K | – | 2326 |
|
|
2024
Q3 | $170K | Sell |
13,361
-31,588
| -70% | -$401K | ﹤0.01% | 1173 |
|
|
2024
Q2 | $754K | Buy |
44,949
+38,799
| +631% | +$651K | 0.01% | 834 |
|
|
2024
Q1 | $92.3K | Buy |
6,150
+6,008
| +4,231% | +$90.1K | ﹤0.01% | 1832 |
|
|
2023
Q4 | $2.13K | Sell |
142
-129,930
| -100% | -$1.95M | ﹤0.01% | 2021 |
|
|
2023
Q3 | $1.82M | Buy |
130,072
+117,718
| +953% | +$1.65M | 0.01% | 814 |
|
|
2023
Q2 | $128K | Buy |
+12,354
| New | +$128K | ﹤0.01% | 1772 |
|
|
2020
Q1 | – | Sell |
-1,478
| Closed | -$49K | – | 2470 |
|
|
2019
Q4 | $49K | Buy |
1,478
+1,079
| +270% | +$35.8K | ﹤0.01% | 2283 |
|
|
2019
Q3 | $10K | Sell |
399
-1
| -0.3% | -$25 | ﹤0.01% | 2146 |
|
|
2019
Q2 | $14K | Sell |
400
-10,838
| -96% | -$379K | ﹤0.01% | 2396 |
|
|
2019
Q1 | $415K | Buy |
11,238
+10,438
| +1,305% | +$385K | 0.01% | 1304 |
|
|
2018
Q4 | $34K | Buy |
800
+703
| +725% | +$29.9K | ﹤0.01% | 1909 |
|
|
2018
Q3 | $5K | Sell |
97
-6,597
| -99% | -$340K | ﹤0.01% | 1820 |
|
|
2018
Q2 | $333K | Buy |
+6,694
| New | +$333K | 0.02% | 1017 |
|